Sanofi builds on mR­NA al­liances with an $805M pact for Ron Re­naud’s Trans­late Bio

A year af­ter Ron Re­naud’s team at RaNA bagged rights to an RNA plat­form at Shire and re­launched as Trans­late Bio, the group has scored a big phar­ma al­liance with Sanofi.

The French gi­ant is hand­ing over a $45 mil­lion up­front to part­ner with Trans­late, which will now set out to de­vel­op mes­sen­ger RNA vac­cines for up to 5 tar­gets. Trans­late will al­so be in line for up to $760 mil­lion in mile­stone cash if the work proves suc­cess­ful.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER